DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dsbtnf/glaxosmithkline) has announced the addition of the "GlaxoSmithKline plc: Company Analysis" company profile to their offering.
This analysis examines the historical and forecast performance for GlaxoSmithKline in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. Gain insight into GlaxoSmithKline's strategic outlook across the next 6 years.Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source. Strategic insight into the prospects for GlaxoSmithKline over the next six years.
- Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
- Benchmark GlaxoSmithKline's performance against key rivals in the prescription pharmaceutical sector
- Assess GlaxoSmithKline's continued diversification strategy with vaccines and emerging markets positioned as key growth opportunities
Key Topics Covered:
SCOPE OF ANALYSIS
EXECUTIVE SUMMARY
- Key findings
- GlaxoSmithKline prescription pharmaceutical sales outlook
- GlaxoSmithKline financial outlook
- SWOT analysis
- Weaknesses
- Opportunities
- Threats
STRATEGIC INSIGHT
- Key findings
- Launch/core/expiry analysis
- Strategic Insight
- Broad-focused emerging markets strategy is key to long-term revenue growth
COMPANY OVERVIEW
- Key findings
- Background
- Post-2008 strategy
- M&A history
OPERATING PERFORMANCE ANALYSIS
- Key findings
- Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2005รข11
- Operating costs and profit analysis
- Operating performance analysis, 2005-17
- Operating performance analysis, 2011-17
APPENDIX
Companies Mentioned
- Abbott Laboratories
- Actelion Ltd
- Allergan Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- Baxter International Inc.
- Bayer AG
- Biogen Idec Inc.
- Bristol-Myers Squibb Company
- Celgene Corporation
- CSL Limited
- Dairy Farm International Holdings Limited
- F. Hoffmann-La Roche Ltd
- Forest Laboratories Inc.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- H. Lundbeck A/S
- Hutchison 3G UK Limited
- Janssen Pharmaceuticals Inc.
- Les Laboratoires Servier
- Merck KGaA
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Shire plc
For more information visit http://www.researchandmarkets.com/research/dsbtnf/glaxosmithkline